Clinical Trials
44 trialsNCT04550429 2026-04-30
Uterine Filling Pressure in Hysteroscopy
Northwestern University
Phase NA Terminated
NCT05017246 2025-07-31
Comparing Intrathecal Morphine and Intraoperative Lidocaine Infusion to Epidural Anesthesia With Postoperative PCA for Patients Undergoing Exploratory Laparotomy
Washington University School of Medicine
Phase 2 Terminated
NCT03194646 2025-07-28
ASTEROID 6
Bayer
Phase 3 Terminated
NCT06106633 2025-04-24
PEDD-UFE
Massachusetts General Hospital
Phase NA Terminated
NCT03240523 2024-10-18
ASTEROID 5
Bayer
Phase 3 Terminated
NCT04849858 2024-08-23
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
University of California, Irvine
Phase 3 Terminated
NCT02209545 2023-09-07
Misoprostol for Reduction of Blood Loss During Fibroid Surgery
Northwestern University
Phase 4 Terminated
NCT03400943 2023-05-03
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 3)
Bayer
Phase 3 Terminated
NCT04073485 2023-05-03
Microwave Ablation for Uterine Fibroids
Chinese University of Hong Kong
Phase NA Terminated
NCT03476928 2022-07-08
ASTEROID 8
Bayer
Phase 3 Terminated
NCT03400956 2022-06-30
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Bayer
Phase 3 Terminated
NCT03342859 2021-01-06
Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned
Bayer
Phase 1 Terminated
NCT02425878 2020-10-14
Ulipristal Acetate 10 mg and Asisted Reproduction
Instituto Valenciano de Infertilidad, IVI VALENCIA
Phase 3 Terminated
NCT04132349 2020-04-13
Ulipristal Acetate in Symptomatic Uterine Fibroid
Mỹ Đức Hospital
Phase 4 Terminated
NCT02825719 2020-04-09
Ulipristal Use in Chinese Population
Queen Mary Hospital, Hong Kong
Phase 4 Terminated
NCT01834703 2019-08-30
Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids
Chinese University of Hong Kong
Phase NA Terminated
NCT03210324 2019-08-07
A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy
China Resources Zizhu Pharmaceutical Co., Ltd.
Phase 4 Terminated
NCT02811159 2019-06-27
An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Terminated
NCT02879058 2019-03-04
Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients
The Cleveland Clinic
Phase NA Terminated
NCT00730886 2018-08-15
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
InSightec
Phase NA Terminated
NCT01842789 2017-08-18
TAG
Acessa Health, Inc.
Phase NA Terminated
NCT02633254 2017-04-07
Targeted Vessel Ablation of Type 3 Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
UMC Utrecht
Phase NA Terminated
NCT01504308 2017-04-05
SOFIA
Philips Healthcare
Phase 2/3 Terminated
NCT01581905 2017-01-20
Study of Conventional Laparoscopic Hysterectomy Versus Robot-Assisted Laparoscopic Hysterectomy at a Teaching Institution
Milton S. Hershey Medical Center
Phase NA Terminated
NCT01344486 2016-10-25
Peritoneal Cavity Conditioning Decreases Pain, Inflammation and Adhesions
University Hospital, Gasthuisberg
Phase 4 Terminated
NCT01555073 2016-07-28
Preemptive Analgesia Following Uterine Artery Embolization
Northwestern University
Phase 4 Terminated
NCT00219778 2016-04-06
A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine Leiomyomas
Poitiers University Hospital
Phase 2 Terminated
NCT01675011 2016-03-11
Embozene Microspheres for Uterine Fibroid Embolization (UFE)
Boston Scientific Corporation
Phase NA Terminated
NCT01226290 2015-04-02
FAST-EU
Gynesonics
Phase NA Terminated
NCT01539187 2015-03-17
FAST-L
Gynesonics
Phase NA Terminated
NCT01786226 2014-09-05
Mifepristone to Treat Uterine Fibroids
Mediterranea Medica S. L.
Phase 2/3 Terminated
NCT00958893 2014-08-25
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
Repros Therapeutics Inc.
Phase 2 Terminated
NCT00683917 2014-08-21
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 2 Terminated
NCT00702702 2014-08-21
Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00735553 2014-08-21
Evaluating the Safety and Efficacy of Proellex® (CDB-4124) in Premenopausal Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00737282 2014-08-21
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00785356 2014-08-21
Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT00853567 2014-08-21
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT01069120 2014-08-21
Safety of 25 and 50 mg Proellex® in the Treatment of Women With Symptomatic Uterine Fibroids
Repros Therapeutics Inc.
Phase 3 Terminated
NCT01311869 2013-10-24
Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids
Meharry Medical College
Phase 2 Terminated
NCT00496080 2012-09-10
DUAO
Ethicon, Inc.
Phase NA Terminated
NCT00496067 2011-03-09
Uterine Artery Occlusion for Fibroid Related Bleeding
Ethicon, Inc.
Phase NA Terminated
NCT01140555 2011-02-17
A Pilot Study to Determine Optimal Procedure Steps to Obtain and Maintain Uterine Artery Occlusion With the D-UAO Device
Ethicon, Inc.
Phase NA Terminated
NCT00584207 2009-04-23
Radiofrequency Ablation of Uterine Fibroids
University of California, Davis
Phase EARLY_PHASE1 Terminated